4 mg CLS-TA

DRUG2 trials

Sponsors

Clearside Biomedical, Inc.

Conditions

Macular EdemaPanuveitisRetinal Vein OcclusionUveitisUveitis, AnteriorUveitis, IntermediateUveitis, Posterior

Phase 2

Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis

CompletedNCT02255032

Clearside Biomedical, Inc.Macular Edema, Panuveitis, Uveitis +3

Start: 2014-10-31End: 2016-01-31Updated: 2021-02-08

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

CompletedNCT02303184

Clearside Biomedical, Inc.Macular Edema, Retinal Vein Occlusion

Start: 2015-01-31End: 2016-03-31Updated: 2021-02-08

Related Papers

Viral Vector Technologies and Strategies: Improving on Nature

International Ophthalmology Clinics2021-07-015 citations